President Donald Trump announced plans for the Department of War to invest $100 million to support pharmaceutical company Antheia, which would use the funds to boost production of medication ingredients at a facility in Winchester, Kentucky. He made the offer conditional on Republicans winning the midterm elections, saying Democrats would not be able to carry it out. Details of the investment remain limited, and the Epoch Times did not receive a response from the Department of War before publication. At a rally in Northern Kentucky, Trump also cited a billion-dollar GE Appliances investment in the state and urged high voter turnout in the upcoming election.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on zerohedge.com ↗
Keywords
Donald Trumpmidterm electionspharmaceuticalsdefense
Open a keyword to see other news on the same topic.
Related news
- Trump Rallies In Kentucky , Promises $5 , 000 Checks | NewsTalk WMEQ
President Donald Trump held a rally at Northern Kentucky University in Highland Heights on Saturday, October 17, urging supporters to vote in the midterms. He warned that “radical Democrats” could undo his administration's accomplishments if they regained power, and promised $5,000 checks to American voters if Republicans kept control of Congress. Trump also announced a potential $100 million investment in a pharmaceutical plant in Winchester, Kentucky, contingent on a Republican victory. Republican candidates Eric Conroy and Ed Gallrein spoke before him, while Indivisible NKY organized protests near the venue.
- Trump Rallies In Kentucky, Promises $5,000 Checks
President Donald Trump held a rally at Northern Kentucky University in Highland Heights on Saturday, October 17, urging voters to turn out in the midterms and calling it the most important midterm in the country's history. He warned that radical Democrats could undo his administration's accomplishments if they regain power, and promised $5,000 checks to American voters if Republicans keep control of Congress. He also announced a potential $100 million investment in a pharmaceutical plant in Winchester, Kentucky, contingent on a Republican victory. Republican candidates Eric Conroy and Ed Gallrein spoke before Trump, while Indivisible NKY organized protests nearby encouraging voter turnout.
- Trump Rallies In Kentucky , Promises $5 , 000 Checks | KFYR 550 AM / 99 . 7 FM
President Donald Trump held a rally at Northern Kentucky University in Highland Heights on Saturday, October 17, urging supporters to vote in the midterms and calling it “the most important midterm in the history of our country.” He warned that “radical Democrats” could undo his administration's accomplishments if they regain power, and promised $5,000 checks to American voters if Republicans keep control of Congress. He also announced a potential $100 million investment in a pharmaceutical plant in Winchester, Kentucky, contingent on a Republican victory. He blamed Democrats for high inflation and energy prices, while Republican candidates Eric Conroy and Ed Gallrein spoke before him. Protests organised by Indivisible NKY took place nearby, with demonstrators encouraging voter turnout.
- Trump Rallies In Kentucky , Promises $5 , 000 Checks
President Donald Trump addressed a rally at Northern Kentucky University in Highland Heights on Saturday, October 17, urging supporters to vote in the midterms. He called the election “the most important midterm in the history of our country” and warned that “radical Democrats” could undo his administration’s accomplishments if they regained power. Trump also promised $5,000 checks to American voters if Republicans keep control of Congress, and announced a potential $100 million investment in a pharmaceutical plant in Winchester, Kentucky, contingent on a Republican victory. Republican candidates Eric Conroy and Ed Gallrein spoke before him, while activists from Indivisible NKY protested nearby to encourage voter turnout.
- Medicare open enrollment : Why premiums could increase for some enrollees
Medicare open enrollment runs from Oct. 15 to Dec. 7, with changes taking effect Jan. 1. The annual out-of-pocket cap for Part D drugs rises to $2,400 from $2,100 in 2026, the standard deductible increases from $615 to $700, and the Trump administration is ending a temporary Part D premium subsidy. According to KFF, enrollees in United AARP-branded Part D plans who don't change plans will see monthly premiums rise by $50 or more in all 50 states, and by more than $75 in 37 states. Fifteen drugs, including Ozempic, Rybelsus and Wegovy, will get Medicare-negotiated prices, and the Centers for Medicare and Medicaid expects the change to reduce prescription drug coverage costs for enrollees by $685 million in 2027. KFF notes many enrollees don't compare plans during open enrollment, even though cheaper options exist.
- Close ally halts purchase of 16 UH-60M helicopters amid dispute with US
Canada has reportedly quietly halted its purchase of 16 UH-60M Black Hawk helicopters from the US just before trade talks with the Trump administration were set to begin, according to CBC. The Sikorsky helicopters were intended for Canada's Special Forces, and CBC sources link the decision to trade and diplomatic tensions. The deal had been approved by the US State Department last year and was due to go to Congress for approval. Relations soured in 2025 after Trump imposed a 25% tariff on Canadian imports, which Canada answered with similar measures, and the US later raised steel and aluminum tariffs to 50%. A recent round of negotiations reportedly collapsed at the last minute due to the hardline stance of US Commerce Secretary Howard Lutnick.
Related markets
Latest news
- J.P. Morgan Stays Top of Extel’s All-America Equities Research Table
Extel's 55th annual All-America Research Team survey ranks J.P. Morgan first in the research team table with 47 published positions, followed by BofA Securities with 44 and Morgan Stanley with 43. UBS posted the largest gain in positions, reaching 42 and climbing to fourth place. In the analyst leaders table, Jefferies takes first place with 43 positions, while UBS leads Extel's weighted ranking of research teams ahead of J.P. Morgan and Evercore ISI. The results reflect the views of 4,451 portfolio managers and analysts at 1,608 institutions across 60 sectors, with 129,919 votes counted. The number of participating institutions fell from 1,705 in 2025, but more firms now sit in the highest commission bands, rising to 89 from 82.
- Visa, Mesh partner to enable crypto spending at 175M merchant locations
Visa and crypto payments network Mesh have partnered so users can spend cryptocurrency and stablecoin balances directly from participating digital wallets at merchants on Visa's network, without transferring funds to a bank account or using a separate crypto card. Merchants receive payments through Visa's existing network without changing their checkout systems. The network covers more than 175 million merchant locations in over 200 countries and territories, and participating wallets and launch dates will be announced later. Mesh will handle funding and conversion between crypto, stablecoins and fiat, as well as onboarding and KYC requirements. The partnership follows Mesh's September integration with Bybit Pay and its $75 million raise in January at a $1 billion valuation.
- Mastercard Brings Its Fraud-Fighting Tools to Stablecoin Payments
Mastercard has launched Stablecoin Security, a tool that lets financial institutions screen stablecoin payments for fraud, scams and sanctions exposure and generate a risk score before a payment settles. Delivered through a platform-agnostic API, it combines Mastercard's payment intelligence with blockchain analytics and launches with Borderless.xyz and Keyrails as initial participants. The move addresses a blind spot flagged by a Bank for International Settlements study, which found nearly 60% of 593 million stablecoin transfers in 2025 were complex, multi-step transactions. The product extends Mastercard's broader stablecoin push, including its Global Money Platform with BVNK, and will launch first in North America, with worldwide availability expected in 2027.
- Better Oil Stock: Chevron (CVX) vs. ExxonMobil (XOM)
The article compares integrated oil majors Chevron (CVX) and ExxonMobil (XOM), whose stocks rose 45% and 58% respectively over the past 12 months as oil prices climbed. Chevron earns about 80% of its profit from upstream operations versus about 70% for ExxonMobil, which has a larger downstream and petrochemicals business. With Brent crude at $110 per barrel, well above breakeven prices of $50 for Chevron and $35 for ExxonMobil, the author argues Chevron's upstream focus suits oil spikes, while ExxonMobil's diversification helps when prices fall. Chevron offers a 3.2% forward yield versus 2.3%, and analysts expect its EPS to grow at a 26% CAGR from 2025 to 2028, compared with 20% for ExxonMobil. Both trade at 15 times next year's earnings, and the author prefers Chevron.
- This High-Yielding Dividend Stock Has Soared Past the "Magnificent Seven" in 2026
Target (TGT) shares are up 57% so far in 2026, outpacing the Magnificent Seven tech group, where Tesla is down 18% and Apple leads with a 26% gain as enthusiasm for AI cools. The stock is still down 39% over five years, with its last positive year in 2021, as consumers have pulled back on discretionary spending, but a new CEO and recent earnings progress have renewed investor interest. Growth in the most recent quarter, which ended Aug. 1, was 5.3%, with comparable growth of 3.6%, which the author sees as decent but not spectacular. Target trades at a P/E of 16 versus about 23 for the S&P 500 and 43 for Walmart, and its dividend yields 3% versus roughly 1% for the market, with 55 consecutive years of increases.
- Here's What a $5,000 Investment in AMD Could Be Worth by 2032
AMD shares have risen 147% in 2026 as of writing, well ahead of the 57% gain in the PHLX Semiconductor Sector index, driven by demand for its server CPUs and GPUs in AI data centers and by gains in the PC market. The data center segment made up 58% of Q2 revenue, rising 107% year over year to $6.7 billion. The company cites an AI data center accelerator market growing at a 45% CAGR through 2030, reaching $1.4 trillion in revenue, and says its server CPUs are used by hyperscalers including Amazon, Microsoft, Oracle, and Google. Other catalysts include its Helios rack-scale systems, semi-custom processors for next-generation Sony and Microsoft consoles, and PC client CPU revenue up 23% to $3.1 billion, with market share estimated at 30.3% versus 23.9% a year earlier, while global PC shipments fell 4%.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.